-
-
-
-
-
-
-
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering
-
-
-
-
-
-
-
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
-
-
-
-
-
-
-
Apogee Therapeutics, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
69,742 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

